Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine

Hauser, 1996, Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota, Mayo Clin Proc, 71, 576, 10.4065/71.6.576

Sander, 2003, The epidemiology of epilepsy revisited, Curr Opin Neurol, 16, 165, 10.1097/00019052-200304000-00008

Sheth, 2004, Metabolic concerns associated with antiepileptic medications, Neurology, 63, S24, 10.1212/WNL.63.10_suppl_4.S24

Ding, 2006, Premature mortality in people with epilepsy in rural China: a prospective study, Lancet Neurol, 5, 823, 10.1016/S1474-4422(06)70528-2

Nilsson, 1997, Cause-specific mortality in epilepsy. A cohort study of more than 9000 patients once hospitalized for epilepsy, Epilepsia, 38, 1062, 10.1111/j.1528-1157.1997.tb01194.x

Annegers, 1984, Heart disease mortality and morbidity in patients with epilepsy, Epilepsia, 25, 699, 10.1111/j.1528-1157.1984.tb03480.x

Cockerell, 1994, Mortality from epilepsy: results from a prospective population-based study, Lancet, 344, 918, 10.1016/S0140-6736(94)92270-5

Gaitatzis, 2004, The epidemiology of the comorbidity of epilepsy in the general population, Epilepsia, 45, 1613, 10.1111/j.0013-9580.2004.17504.x

Muuronen, 1985, Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study, Br Med J Clin Res Ed, 291, 1481, 10.1136/bmj.291.6507.1481

Isojärvi, 1993, Serum lipid levels during carbamazepine medication: a prospective study, Arch Neurol, 50, 590, 10.1001/archneur.1993.00540060030012

Sudhop, 1999, Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study, Epilepsia, 40, 480, 10.1111/j.1528-1157.1999.tb00744.x

Ben-Menachem, 2003, Levetiracetam: treatment in epilepsy, Exp Opin Pharmacother, 4, 2079, 10.1517/14656566.4.11.2079

Mintzer, 2009, Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein, Ann Neurol, 65, 448, 10.1002/ana.21615

Commission on classification and terminology of the International League Against Epilepsy, 1989, Proposal for revised classification of epilepsies and epileptic syndromes, Epilepsia, 30, 389, 10.1111/j.1528-1157.1989.tb05316.x

Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9

Tholstrup, 2009, Alkohol intake, myocardial infarction, biochemical risk factors, and alcohol dehydrogenase genotypes, Circ Cardiovasc Genet, 2, 5007

Livingston, 1976, Phenytoin and serum cholesterol (letter), Br Med J, 1, 586, 10.1136/bmj.1.6009.586-b

Zaccara, 2009, Neurological comorbidity and epilepsy: implications for treatment, Acta Neurol Scand, 120, 1, 10.1111/j.1600-0404.2008.01146.x